{"id":"https://openalex.org/W4200435825","doi":"https://doi.org/10.1111/bjh.17984","title":"Long\u2010term efficacy of first\u2010line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials","display_name":"Long\u2010term efficacy of first\u2010line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-05","ids":{"openalex":"https://openalex.org/W4200435825","doi":"https://doi.org/10.1111/bjh.17984","pmid":"https://pubmed.ncbi.nlm.nih.gov/34865212","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9299890"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.17984","doi":"https://doi.org/10.1111/bjh.17984","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17984","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17984","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200435825"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17984","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026842309","display_name":"John Nathan Allan","orcid":"https://orcid.org/0000-0002-2088-0899","observed_orcids":["https://orcid.org/0000-0002-2088-0899"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John N. Allan","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY, USA"],"raw_orcid":"https://orcid.org/0000-0002-2088-0899","affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033825180","display_name":"Tait D. Shanafelt","orcid":"https://orcid.org/0000-0002-7106-5202","observed_orcids":["https://orcid.org/0000-0002-7106-5202"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tait Shanafelt","raw_affiliation_strings":["Stanford University Medical Center, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University Medical Center, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030524385","display_name":"Adrian U. Wiestner","orcid":"https://orcid.org/0000-0002-3533-2924","observed_orcids":["https://orcid.org/0000-0002-3533-2924"]},"institutions":[{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adrian Wiestner","raw_affiliation_strings":["National Heart, Lung, and Blood Institute, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart, Lung, and Blood Institute, Bethesda, MD, USA","institution_ids":["https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554686","display_name":"Carol Moreno","orcid":"https://orcid.org/0000-0003-3275-0271","observed_orcids":["https://orcid.org/0000-0003-3275-0271"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carol Moreno","raw_affiliation_strings":["Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3275-0271","affiliations":[{"raw_affiliation_string":"Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I2801795740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006104041","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0002-2481-7504","observed_orcids":["https://orcid.org/0000-0002-2481-7504"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan M. O\u2019Brien","raw_affiliation_strings":["Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101818737","display_name":"Jianling Li","orcid":"https://orcid.org/0000-0001-6074-8852","observed_orcids":["https://orcid.org/0000-0001-6074-8852"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jianling Li","raw_affiliation_strings":["Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104857697","display_name":"Gabriel S. Krigsfeld","orcid":"https://orcid.org/0000-0003-4002-3699","observed_orcids":["https://orcid.org/0000-0003-4002-3699"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriel Krigsfeld","raw_affiliation_strings":["Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103270876","display_name":"James P. Dean","orcid":"https://orcid.org/0000-0001-8058-1682","observed_orcids":["https://orcid.org/0000-0001-8058-1682"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James P. Dean","raw_affiliation_strings":["Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055037645","display_name":"Inhye E. Ahn","orcid":"https://orcid.org/0000-0003-3717-287X","observed_orcids":["https://orcid.org/0000-0003-3717-287X"]},"institutions":[{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Inhye E. Ahn","raw_affiliation_strings":["National Heart, Lung, and Blood Institute, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart, Lung, and Blood Institute, Bethesda, MD, USA","institution_ids":["https://openalex.org/I4210106489"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5026842309"],"corresponding_institution_ids":["https://openalex.org/I4387153466"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":{"value":4600,"currency":"USD","value_usd":4600},"fwci":6.2425,"has_fulltext":true,"cited_by_count":75,"citation_normalized_percentile":{"value":0.97457088,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"196","issue":"4","first_page":"947","last_page":"953"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tp53-aberrations","display_name":"TP53 aberrations","score":0.984000027179718},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.8870000243186951},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.996999979019165},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.8349999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9909999966621399},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5830000042915344},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9628862142562866},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.8824194073677063},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8055545091629028},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6881033778190613},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5599915981292725},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5429080128669739},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4599669575691223},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44399967789649963},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4124548137187958},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30563682317733765},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.23887863755226135}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1111/bjh.17984","doi":"https://doi.org/10.1111/bjh.17984","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17984","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17984","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9299890","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9299890/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmid:34865212","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34865212","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:ddd.uab.cat:282983","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/282983","pdf_url":null,"source":{"id":"https://openalex.org/S4306400380","display_name":"Dip\u00f2sit Digital de Documents de la UAB (Universitat Aut\u00f2noma de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123044942","host_organization_name":"Universitat Aut\u00f2noma de Barcelona","host_organization_lineage":["https://openalex.org/I123044942"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt6f10v81j","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/6f10v81j","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, vol 196, iss 4","raw_type":"article"},{"id":"pmh:oai:recercat.cat:2072/470447","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/282983","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/bjh.17984","doi":"https://doi.org/10.1111/bjh.17984","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.17984","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.17984","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G190157698","display_name":"ECOG-ACRIN Network Group Operations Center","funder_award_id":"U10CA180820","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000879350","display_name":"ECOG-ACRIN Biospecimen Bank to Support NCTN","funder_award_id":"U24CA196172","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306571","display_name":"American Society of Hematology","ror":"https://ror.org/02nw48b86"},{"id":"https://openalex.org/F4320309042","display_name":"American College of Radiology Imaging Network","ror":"https://ror.org/01cywgd53"},{"id":"https://openalex.org/F4320317664","display_name":"ECOG-ACRIN Cancer Research Group","ror":"https://ror.org/00d3km654"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320333648","display_name":"Pharmacyclics","ror":"https://ror.org/03hm8w204"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200435825.pdf","grobid_xml":"https://content.openalex.org/works/W4200435825.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1960354891","https://openalex.org/W2015299436","https://openalex.org/W2016042196","https://openalex.org/W2023976667","https://openalex.org/W2136272158","https://openalex.org/W2140606816","https://openalex.org/W2142741025","https://openalex.org/W2233614027","https://openalex.org/W2295348655","https://openalex.org/W2337485820","https://openalex.org/W2507865108","https://openalex.org/W2519500141","https://openalex.org/W2752308580","https://openalex.org/W2789078984","https://openalex.org/W2790385276","https://openalex.org/W2790448887","https://openalex.org/W2901396567","https://openalex.org/W2902484351","https://openalex.org/W2902706178","https://openalex.org/W2966190920","https://openalex.org/W2973195462","https://openalex.org/W2980937306","https://openalex.org/W2981897797","https://openalex.org/W2991221047","https://openalex.org/W3045542125","https://openalex.org/W3045571650","https://openalex.org/W3048067521","https://openalex.org/W3092937247","https://openalex.org/W3158566223","https://openalex.org/W3175572241","https://openalex.org/W4213170825","https://openalex.org/W4220652578"],"related_works":["https://openalex.org/W3095638461","https://openalex.org/W4417438094","https://openalex.org/W3211864651","https://openalex.org/W2908806031","https://openalex.org/W4239835146","https://openalex.org/W4254394618","https://openalex.org/W2023976667","https://openalex.org/W4382402712","https://openalex.org/W3158566223","https://openalex.org/W4389232644"],"abstract_inverted_index":{"TP53":[0,4,33,57,89,96,192],"aberrations":[1,34,58],"[del(17p)":[2],"or":[3,68],"mutation]":[5],"predict":[6],"poor":[7],"survival":[8,111,116,120],"with":[9,13,30,56,62,72,95,191],"chemoimmunotherapy":[10],"in":[11,28,35,70,139,149,189],"patients":[12,29,55,81,94,155,190],"chronic":[14],"lymphocytic":[15],"leukaemia":[16],"(CLL).":[17],"We":[18],"evaluated":[19],"long-term":[20,183],"efficacy":[21],"and":[22,47,118,128,200],"safety":[23,145],"of":[24,85,92,104,141,154,166,185],"first-line":[25,60,186],"ibrutinib-based":[26,187],"therapy":[27,188],"CLL":[31],"bearing":[32],"a":[36,101],"pooled":[37,51],"analysis":[38,52],"across":[39],"four":[40,124,167],"studies:":[41],"PCYC-1122e,":[42],"RESONATE-2":[43],"(PCYC-1115/16),":[44],"iLLUMINATE":[45],"(PCYC-1130)":[46],"ECOG-ACRIN":[48],"E1912.":[49],"The":[50],"included":[53],"89":[54,80,86],"receiving":[59],"treatment":[61,159],"single-agent":[63],"ibrutinib":[64,69,158],"(n":[65,76],"=":[66,77],"45)":[67],"combination":[71],"an":[73],"anti-CD20":[74],"antibody":[75],"44).":[78],"All":[79],"had":[82],"del(17p)":[83],"(53%":[84],"patients)":[87],"and/or":[88],"mutation":[90],"(91%":[91],"58":[93],"sequencing":[97],"results":[98,173],"available).":[99],"With":[100,163],"median":[102,109,164],"follow-up":[103,165],"49\u00b78":[105],"months":[106],"(range,":[107],"0\u00b71-95\u00b79),":[108],"progression-free":[110],"was":[112,134],"not":[113],"reached.":[114],"Progression-free":[115],"rate":[117,121,133],"overall":[119],"estimates":[122],"at":[123,160,195],"years":[125,168],"were":[126,147],"79%":[127],"88%,":[129],"respectively.":[130],"Overall":[131],"response":[132,138],"93%,":[135],"including":[136],"complete":[137],"39%":[140],"patients.":[142],"No":[143],"new":[144],"signals":[146],"identified":[148],"this":[150,175],"analysis.":[151],"Forty-six":[152],"percent":[153],"remained":[156],"on":[157],"last":[161],"follow-up.":[162],"(up":[169],"to":[170],"eight":[171],"years),":[172],"from":[174],"large,":[176],"pooled,":[177],"multi-study":[178],"data":[179],"set":[180],"suggest":[181],"promising":[182],"outcomes":[184],"aberrations.":[193],"Registered":[194],"ClinicalTrials.gov":[196],"(NCT01500733,":[197],"NCT01722487,":[198],"NCT02264574":[199],"NCT02048813).":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200435825","counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-12-31T00:00:00"}
